TELUS to provide free smartphones and data plans to youth leaving foster care in Prince Edward Island
TELUS and Children’s Aid Foundation of Canada partner to keep vulnerable Canadian youth safe and connected to vital resources with […]
Axovant Announces First Parkinson’s Disease Gene Therapy R&D Day and Participation in Upcoming September Conferences”
– Parkinson’s Disease R&D Day to be hosted by Gavin Corcoran, MD, Chief R&D Officer, on October 30th, […]
ICU Medical, Inc. to Present at Morgan Stanley 18th Annual Global Healthcare Conference
SAN CLEMENTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and […]
OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility Test
Ares Genetics nominated for the 40th Austrian Innovation Award by Federal Ministry for Digital and Economic AffairsARESupa – Universal Pathogenome […]
Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis
LEXINGTON, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing […]
New Biogen Data Presented at ACTRIMS-ECTRIMS Advance Understanding of Clinical and Health Disparities in MS
Data highlights socio-demographic and clinical disparities to help raise awareness of health inequities and inform future treatment planningReal-world data from […]
Revolution Medicines to Participate in 2nd Annual RAS-Targeted Drug Development Conference
REDWOOD CITY, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused […]
Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
Pivotal Phase 3 clinical trial of oral tebipenem HBr met primary endpoint, demonstrating statistical non-inferiority versus intravenous ertapenem in patients […]
TSX News -
Marathon Gold Reports Additional Exploration Drill Results from the Valentine Gold Project
TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”; TSX: MOZ) is pleased to report […]
REPEAT – Developing Patent Portfolio: Taat Completes Filing of its First U.S. Patent for Beyond Tobacco™ Base Material Refinement Process
In preparation for launching Beyond Tobacco™ cigarettes, which is set to take place in Q4 2020, the Company has completed […]
